HOME >> BIOLOGY >> NEWS
AutovaxID-C introduced by Accentia Biopharmaceuticals

Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI), announced that its subsidiary, Biovest International, Inc., presented its newest cell culture instrument, the AutovaxIDTM-C, at the Cancer Research Institute's recent meeting, "Cancer Vaccines: Barriers, Endpoints and Opportunities." This was the first introduction of the AutovaxID-C to the biotech industry.

The AutovaxID-C is an automated hollow fiber cell culture instrument that collects secreted protein from cells and controls the growth of the cells automatically for 30 days or more. Growth takes place in sterile, disposable patient specific modules that are bar coded for ease of tracking and identification. Biovest believes that the AutovaxID-C instrument represents a significant advance in personalized medicine because it reduces the possibility of cross contamination and allows segregation of patient specific vaccine batches. Further expected advantages include reduced manpower requirements, automated batch record generation and improved efficiency in facility design.

"Cancer vaccines are one of the most exciting and promising fields of personalized medicine," said Carl M. Cohen, Ph.D., Chief Operating Officer, Biovest. "The production of a patient specific vaccine to immunize individuals against their own cancers has been a goal of investigators in both academia and industry. Biovest is currently testing an idiotype vaccine to treat follicular non-Hodgkin's lymphomas in a Phase 3 clinical trial."

"Our approach is unique in that it uses hybridoma technology to produce complete idiotype proteins identical to those on the tumor B cells. Results from early clinical trials are very encouraging and generating a lot of excitement in the medical community; however, there has been some concern about the challenge of producing personalized vaccines on a large scale. At this meeting we presented the first of a suite of instruments, designed and produced by the Biovest Advanced Inst
'"/>

Contact: Sherran Brewer
sbrewer@accentia.net
866-481-9020
SciWords
8-Dec-2005


Page: 1 2 3

Related biology news :

1. AutovaxID-C introduced by Biovest International
2. First SCID gene chip to be introduced at Academy meeting on immunodeficiencies
3. Ape computers introduced in the US
4. FDA grants Accentia Biopharmaceuticals...
5. Accentia Biopharmaceuticals announces option agreement with Mayo
6. Accentia Biopharmaceuticals acquires exclusive license
7. Accentia Biopharmaceuticals, Inc. launches CRSFungal Profile

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... ... August 19, 2020 , ... The 19th Annual Bio-IT ... data science, informatics and IT leaders goes VIRTUAL and announces its updated event ... change, Bio-IT takes the leadership role of keeping our life science community connected ...
(Date:8/7/2020)... ... 06, 2020 , ... Alucio™, a fast-growing provider of cloud-based ... and Jessica Wong have joined the company’s leadership team as Vice President of ... heads development efforts for Alucio’s flagship product, Beacon, an innovative cloud-based content management ...
(Date:7/31/2020)... ... July 30, 2020 , ... BioFactura, Inc. today announced ... the Joint Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) of the Department ... scale-up a highly efficient mammalian cell culture-based bioprocess suitable to meet surge requirement ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... ... the launch of its new tagline, “BUILDING FOR LIFE.” The adoption of this ... around the globe, requiring fast track capacity to provide patients with urgently needed ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas Medicine, ... provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell ... into a strategic partnership whereby Catalent will provide support for the development, manufacturing, ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... sciences industry, today announced the release of its signature product called Beacon ... Liaisons (MSLs) and other field medical professionals. , Beacon helps MSLs ...
(Date:7/18/2020)... ... 16, 2020 , ... “We are thrilled to deliver this new technology to ... of its kind on the market and we were pleased that the IFT jury ... traditional cultured ingredients, creating a natural way to extend the shelf life and improve ...
Breaking Biology Technology:
Cached News: